Semaglutide Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Semaglutide Tablet (tablet) from Novo Nordisk, Inc. with status To Be Discontinued. The shortage was first posted on 06/04/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Novo Nordisk, Inc.
- Package NDC
- 0169-4314-30
- Dosage Form
- Tablet
- Presentation
- Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)
- Initial Posting
- 06/04/2026
- Revised Date